United States · FDA National Drug Code directory
RIVFLOZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-5308_758d66fb-0447-4f26-905f-595b182aebdc
- Product NDC
- 0169-5308
- Form
- INJECTION, SOLUTION
- Composition / generic term
- nedosiran
- Labeler
- Novo Nordisk
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240219
- Source listing expiry
- 20261231
Source-listed ingredients
- NEDOSIRAN SODIUM — 80 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0169-5308-01) / .5 mL in 1 VIAL · 0169-5308-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →